Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - hidromorfona hidrocloruro - comprimido de liberaciÓn prolongada - 4 mg - hidromorfona hidrocloruro 4 mg - hidromorfona

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen-cilag, s.a. - hidromorfona hidrocloruro - excipientes: - opioides - alcaloides naturales del opio - hidromorfona

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - hidromorfona hidrocloruro - comprimido de liberaciÓn prolongada - 8 mg - hidromorfona hidrocloruro 8 mg - hidromorfona

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 16mg (+ 9% overage to account for residual drug retained in capsule shell) - modified release tablet - 16 mg - active: hydromorphone hydrochloride 16mg (+ 9% overage to account for residual drug retained in capsule shell) excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a opadry yellow y-30-12863-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 32mg - modified release tablet - 32 mg - active: hydromorphone hydrochloride 32mg excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black iron oxide yellow macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a opadry white y-30-18037 polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 4mg (+ 9% system overage) - modified release tablet - 4 mg - active: hydromorphone hydrochloride 4mg (+ 9% system overage) excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black iron oxide yellow macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 64mg - modified release tablet - 64 mg - active: hydromorphone hydrochloride 64mg excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry blue y-30-10701 opadry clear ys-1-19025-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - hydromorphone hydrochloride 8mg (+ 9% overage to account for residual drug retained in capsule shell) - modified release tablet - 8 mg - active: hydromorphone hydrochloride 8mg (+ 9% overage to account for residual drug retained in capsule shell) excipient: butylated hydroxytoluene cellulose acetate hypromellose iron oxide black macrogol 3350 magnesium stearate opacode black ns-78-17821 opadry clear ys-1-19025-a opadry red y-30-15595-a polyethylene oxide povidone sodium chloride - jurnista is indicated in the treatment of moderate to severe chronic pain.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - hydromorphone hydrochloride -

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 8 mg corresp. hydromorphonum 7.12 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 7.02 mg, hypromellosum, e 172 (nigrum), lactosum 0.012 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 4.36 mg, hypromellosum, e 171, e 172 (rubrum), triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika